Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ADTL-EI1712 is a dual inhibitor of ERK1 and ERK5 (IC50s = 40.43 and 64.5 nM, respectively).1It reduces ERK1 and ERK5 activity by 93.5% and 89.4%, respectively, but also inhibits ERK2 activity by 92.7%, in a panel of 100 kinases at 1 μM. ADTL-EI1712 inhibits proliferation of HL-60 and MKN74, but not HeLa, cancer cells (IC50s = 1.26, 2.55, and <50 μM, respectively). It reduces tumor growth and intratumor phosphorylation of ERK1/2 and ERK5 in an MKN74 mouse xenograft model when administered at a dose of 50 mg/kg per day.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 155.00 | |
5 mg | 35 days | $ 294.00 | |
10 mg | 35 days | $ 528.00 | |
25 mg | 35 days | $ 1,120.00 |
Description | ADTL-EI1712 is a dual inhibitor of ERK1 and ERK5 (IC50s = 40.43 and 64.5 nM, respectively).1It reduces ERK1 and ERK5 activity by 93.5% and 89.4%, respectively, but also inhibits ERK2 activity by 92.7%, in a panel of 100 kinases at 1 μM. ADTL-EI1712 inhibits proliferation of HL-60 and MKN74, but not HeLa, cancer cells (IC50s = 1.26, 2.55, and >50 μM, respectively). It reduces tumor growth and intratumor phosphorylation of ERK1/2 and ERK5 in an MKN74 mouse xenograft model when administered at a dose of 50 mg/kg per day. |
Synonyms | ADTL-EI1712 |
Molecular Weight | 505.44 |
Formula | C22H18Cl2N4O2S2 |
CAS No. | 2414916-45-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 1 mg/mL
DMSO: 1 mg/mL
DMSO:PBS (pH 7.2) (1:3): 0.25 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ADTL-EI1712 2414916-45-1 ADTLEI1712 ADTL-EI-1712 ADTL EI1712 ADTL-EI 1712 inhibitor inhibit